Market Tracker

05/30 3:11am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

455.17
Delayed Data
As of May 26
 -0.53 / -0.12%
Today’s Change
325.35
Today|||52-Week Range
464.40
+23.99%
Year-to-Date
Charting the Biotechs
May 26 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data
May 24 / Zacks.com - Paid Partner Content
Regeneron Presents Positive Phase II Data on HoFH Candidate
May 25 / Zacks.com - Paid Partner Content
Merck Presents Phase II Data on Chronic Cough Candidate
May 23 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene
May 25 / Zacks.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets FDA Approval for Arthritis
May 23 / Zacks.com - Paid Partner Content
Boston Common Asset Management, LLC Buys Sociedad Quimica Y Minera De Chile SA, Albem...
May 25 / GuruFocus News - Paid Partner Content
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose
May 22 / Zacks.com - Paid Partner Content
Theravance/Mylan Presents Phase III Data on COPD Candidate
May 24 / Zacks.com - Paid Partner Content
Compugen (CGEN) Worth a Look: Stock Adds 10.4% in Session
May 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close455.70
Today’s open456.70
Day’s range453.35 - 459.25
Volume475,520
Average volume (3 months)909,118
Market cap$48.4B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+13.47%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+18.44%
P/E ratio55.0
Price/Sales8.79
Price/Book10.84

Competitors

 Today’s
change
Today’s
% change
SHPGShire-7.64-4.13%
BAXBaxter International...-0.50-0.85%
ZTSZoetis Inc+0.03+0.05%
VRTXVertex Pharmaceutica...+1.32+1.11%
Data as of 4:14pm ET, 05/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$3.18
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts